Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Total Current Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
Total Current Liabilities ₹107 Cr₹113 Cr₹78 Cr₹59 Cr₹66 Cr

What is the latest Total Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Total Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is ₹107 Cr based on Mar2024 Consolidated results.
Year Total Current Liabilities
Mar2024₹107 Cr
Mar2023₹113 Cr
Mar2022₹78 Cr
Mar2017₹59 Cr
Mar2016₹66 Cr

How is Total Current Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Total Current Liabilities % Change
Mar2024 ₹107 Cr
-5.86
Mar2023 ₹113 Cr
44.60
Mar2022 ₹78 Cr
33.01
Mar2017 ₹59 Cr
-10.43
Mar2016 ₹66 Cr -

Compare Total Current Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,788.8 Cr -6.1% -2.3% 52.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹398,686.0 Cr 0.8% -1.3% 10.6% Stock Analytics
DIVIS LABORATORIES ₹176,075.0 Cr 1.5% 2.3% 47.2% Stock Analytics
CIPLA ₹121,023.0 Cr -0.3% 0.9% -3.8% Stock Analytics
DR REDDYS LABORATORIES ₹109,971.0 Cr -0.1% 7.2% 11.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,121.0 Cr -2.7% -0.3% 9.9% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-6.1%

-2.3%

52.8%

SENSEX

0.1%

1.2%

6%


You may also like the below Video Courses